author_facet Fernandez-Egea, Emilio
Bernardo, Miguel
Donner, Thomas
Conget, Ignacio
Parellada, Eduard
Justicia, Azucena
Esmatjes, Enric
Garcia-Rizo, Clemente
Kirkpatrick, Brian
Fernandez-Egea, Emilio
Bernardo, Miguel
Donner, Thomas
Conget, Ignacio
Parellada, Eduard
Justicia, Azucena
Esmatjes, Enric
Garcia-Rizo, Clemente
Kirkpatrick, Brian
author Fernandez-Egea, Emilio
Bernardo, Miguel
Donner, Thomas
Conget, Ignacio
Parellada, Eduard
Justicia, Azucena
Esmatjes, Enric
Garcia-Rizo, Clemente
Kirkpatrick, Brian
spellingShingle Fernandez-Egea, Emilio
Bernardo, Miguel
Donner, Thomas
Conget, Ignacio
Parellada, Eduard
Justicia, Azucena
Esmatjes, Enric
Garcia-Rizo, Clemente
Kirkpatrick, Brian
British Journal of Psychiatry
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Psychiatry and Mental health
author_sort fernandez-egea, emilio
spelling Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian 0007-1250 1472-1465 Royal College of Psychiatrists Psychiatry and Mental health http://dx.doi.org/10.1192/bjp.bp.108.052605 <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec> Metabolic profile of antipsychotic-naive individuals with non-affective psychosis British Journal of Psychiatry
doi_str_mv 10.1192/bjp.bp.108.052605
facet_avail Online
Free
finc_class_facet Medizin
Psychologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE5Mi9ianAuYnAuMTA4LjA1MjYwNQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE5Mi9ianAuYnAuMTA4LjA1MjYwNQ
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint Royal College of Psychiatrists, 2009
imprint_str_mv Royal College of Psychiatrists, 2009
issn 0007-1250
1472-1465
issn_str_mv 0007-1250
1472-1465
language English
mega_collection Royal College of Psychiatrists (CrossRef)
match_str fernandezegea2009metabolicprofileofantipsychoticnaiveindividualswithnonaffectivepsychosis
publishDateSort 2009
publisher Royal College of Psychiatrists
recordtype ai
record_format ai
series British Journal of Psychiatry
source_id 49
title Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_unstemmed Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_full Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_fullStr Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_full_unstemmed Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_short Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_sort metabolic profile of antipsychotic-naive individuals with non-affective psychosis
topic Psychiatry and Mental health
url http://dx.doi.org/10.1192/bjp.bp.108.052605
publishDate 2009
physical 434-438
description <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec>
container_issue 5
container_start_page 434
container_title British Journal of Psychiatry
container_volume 194
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348616051916807
geogr_code not assigned
last_indexed 2024-03-01T18:13:58.419Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Metabolic+profile+of+antipsychotic-naive+individuals+with+non-affective+psychosis&rft.date=2009-05-01&genre=article&issn=1472-1465&volume=194&issue=5&spage=434&epage=438&pages=434-438&jtitle=British+Journal+of+Psychiatry&atitle=Metabolic+profile+of+antipsychotic-naive+individuals+with+non-affective+psychosis&aulast=Kirkpatrick&aufirst=Brian&rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.108.052605&rft.language%5B0%5D=eng
SOLR
_version_ 1792348616051916807
author Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian
author_facet Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian, Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian
author_sort fernandez-egea, emilio
container_issue 5
container_start_page 434
container_title British Journal of Psychiatry
container_volume 194
description <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec>
doi_str_mv 10.1192/bjp.bp.108.052605
facet_avail Online, Free
finc_class_facet Medizin, Psychologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE5Mi9ianAuYnAuMTA4LjA1MjYwNQ
imprint Royal College of Psychiatrists, 2009
imprint_str_mv Royal College of Psychiatrists, 2009
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 0007-1250, 1472-1465
issn_str_mv 0007-1250, 1472-1465
language English
last_indexed 2024-03-01T18:13:58.419Z
match_str fernandezegea2009metabolicprofileofantipsychoticnaiveindividualswithnonaffectivepsychosis
mega_collection Royal College of Psychiatrists (CrossRef)
physical 434-438
publishDate 2009
publishDateSort 2009
publisher Royal College of Psychiatrists
record_format ai
recordtype ai
series British Journal of Psychiatry
source_id 49
spelling Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian 0007-1250 1472-1465 Royal College of Psychiatrists Psychiatry and Mental health http://dx.doi.org/10.1192/bjp.bp.108.052605 <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec> Metabolic profile of antipsychotic-naive individuals with non-affective psychosis British Journal of Psychiatry
spellingShingle Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian, British Journal of Psychiatry, Metabolic profile of antipsychotic-naive individuals with non-affective psychosis, Psychiatry and Mental health
title Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_full Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_fullStr Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_full_unstemmed Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_short Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_sort metabolic profile of antipsychotic-naive individuals with non-affective psychosis
title_unstemmed Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
topic Psychiatry and Mental health
url http://dx.doi.org/10.1192/bjp.bp.108.052605